跳至主要内容
临床试验/NCT04796571
NCT04796571已完成不适用

Care Coordination and Proactive Care to Improve Utilization of Resources and Reduce Expenditure in High Risk Inflammatory Bowel Disease (IBD) Patients

University of Michigan2 个研究点 分布在 1 个国家目标入组 425 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
425
试验地点
2
主要终点
IBD-related charges per person

研究概览

简要总结

The study team performed a randomized controlled trial to evaluate the efficacy of a care coordination intervention composed of proactive symptom monitoring and algorithm-based triggers to improve patient reported outcomes (PROs) and healthcare expenditures for high-risk patients with IBD. Enrolled patients with IBD were randomized to proactive symptom monitoring with the support of a care coordinator or usual care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

Blinding of participants was not possible because telephone visits were only offered to participants in the intervention arm. Investigators were blinded to the randomization order, but patients, staff, and providers were not blinded to arm assignment. The investigators who validated the data and performed the data analysis remained blinded to patient group assignment.

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • established diagnosis of IBD (with at least 3 office visits)
  • followed in GI clinic within 1 year of enrollment
  • in top 20th percentile of predicted risk for subsequent healthcare utilization (previously validated model)

排除标准

  • non-IBD driver for high utilization (e.g., active cancer undergoing treatment
  • A life expectancy of less than one year, were excluded from participation.

结局指标

主要结局

IBD-related charges per person

时间窗: 12 months

extracted charges where IBD was the primary diagnosis over study period

Change in patient reported outcome (PRO) scores

时间窗: 9 months

Patient Reported Outcome (PRO) measurements were administered on a monthly basis. The validated Crohn's (CD)-PRO or ulcerative colitis (UC)-PRO were used according to the patient's IBD type (Crohn's or ulcerative colitis). Both the CD-PRO and UC-PRO are a set of standardized and validated instruments based on the Crohn's Disease Activity Index and Mayo Clinic Score respectively, which includes six domains: daily bowel movements, functional symptoms, systemic symptoms, daily coping, weekly life impact, and weekly emotional impact. Scores are calculated a composite score across all domains where a score of 0 represents no symptom activity and a score of 40 represents the highest possible symptom burden. These were not two separate outcomes, rather two independent measurement instruments (scored on the same scale) specific to the patient's IBD-type to address the specific needs/concerns of the patients based on disease type.

Total healthcare charges per person

时间窗: 12 months

all extracted charges over study period

次要结局

  • Proportion of hospitalizations per person(12 months)
  • Emergency Department (ED) visits per person(12 months)
  • Change in IBD medication utilization(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Higgins

Professor of Internal Medicine

University of Michigan

研究点 (2)

Loading locations...

相似试验